Home › Employers › Simple HealthKit Inc.
Simple HealthKit Inc.: H-1B salaries and sponsorship
Simple HealthKit Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $103,646.
Does Simple HealthKit Inc. sponsor H-1B visas?
Simple HealthKit Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 9, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Program Manager, Biotechnology | 1 | $70,283 |
| Project Manager, Biotechnology | 1 | $1,452,420 |
| Operations Research Analyst – Strategic Partnerships | 1 | $103,646 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $70,283 |
| FY2026 | 2 | $778,033 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Operations Research Analyst – Strategic Partnerships | $103,646–$125,694 Level II | Milpitas, CA | Apr 9, 2026 | Oct 1, 2026 | Certified |
| Project Manager, Biotechnology | $1,452,420–$1,802,616 Level II | Milpitas, CA | Feb 7, 2026 | Feb 16, 2026 | Certified |
| Program Manager, Biotechnology | $70,283–$100,984 Level I | Fremont, CA | Jun 13, 2023 | Oct 1, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).